Peptide antimicrobial agents.

Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc Natl Acad Sci U S A (2008) 2.35

CAMP: a useful resource for research on antimicrobial peptides. Nucleic Acids Res (2009) 2.02

Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun (2008) 1.77

Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology (2007) 1.77

Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem (2009) 1.68

The roles of antimicrobial peptides in innate host defense. Curr Pharm Des (2009) 1.58

Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Biopolymers (2008) 1.51

The GraRS regulatory system controls Staphylococcus aureus susceptibility to antimicrobial host defenses. BMC Microbiol (2008) 1.51

Induction of group A Streptococcus virulence by a human antimicrobial peptide. Proc Natl Acad Sci U S A (2008) 1.45

Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance. Front Microbiol (2013) 1.42

Antimicrobial peptides. Pharmaceuticals (Basel) (2013) 1.37

Salivary defense proteins: their network and role in innate and acquired oral immunity. Int J Mol Sci (2012) 1.32

Development of topical microbicides to prevent the sexual transmission of HIV. Antiviral Res (2009) 1.30

Defensins knowledgebase: a manually curated database and information source focused on the defensins family of antimicrobial peptides. Nucleic Acids Res (2006) 1.28

Escherichia coli cell surface perturbation and disruption induced by antimicrobial peptides BP100 and pepR. J Biol Chem (2010) 1.27

Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins. Antimicrob Agents Chemother (2008) 1.20

Alpha-helical cationic antimicrobial peptides: relationships of structure and function. Protein Cell (2010) 1.19

Marine sponge derived natural products between 2001 and 2010: trends and opportunities for discovery of bioactives. Mar Drugs (2014) 1.19

Host defense peptides in the oral cavity and the lung: similarities and differences. J Dent Res (2008) 1.19

GraXSR proteins interact with the VraFG ABC transporter to form a five-component system required for cationic antimicrobial peptide sensing and resistance in Staphylococcus aureus. Antimicrob Agents Chemother (2011) 1.18

Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2. Antimicrob Agents Chemother (2008) 1.16

Isolation of a Paenibacillus sp. strain and structural elucidation of its broad-spectrum lipopeptide antibiotic. Appl Environ Microbiol (2012) 1.16

Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold. Antimicrob Agents Chemother (2010) 1.15

Antimicrobial peptides with cell-penetrating peptide properties and vice versa. Eur Biophys J (2011) 1.12

Investigation of the Staphylococcus aureus GraSR regulon reveals novel links to virulence, stress response and cell wall signal transduction pathways. PLoS One (2011) 1.12

Connecting peptide physicochemical and antimicrobial properties by a rational prediction model. PLoS One (2011) 1.11

Polysialic acid, a glycan with highly restricted expression, is found on human and murine leukocytes and modulates immune responses. J Immunol (2008) 1.11

Peptide antibiotic sensing and detoxification modules of Bacillus subtilis. Antimicrob Agents Chemother (2010) 1.09

High-throughput sequence analysis of turbot (Scophthalmus maximus) transcriptome using 454-pyrosequencing for the discovery of antiviral immune genes. PLoS One (2012) 1.08

Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PLoS One (2011) 1.08

Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database. Antimicrob Agents Chemother (2010) 1.08

Short alkylated peptoid mimics of antimicrobial lipopeptides. Antimicrob Agents Chemother (2010) 1.08

New tick defensin isoform and antimicrobial gene expression in response to Rickettsia montanensis challenge. Infect Immun (2007) 1.07

Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections. Plant Biotechnol J (2011) 1.07

Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13. J Antimicrob Chemother (2008) 1.06

Poisson-Nernst-Planck models of nonequilibrium ion electrodiffusion through a protegrin transmembrane pore. PLoS Comput Biol (2009) 1.06

Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components. BMC Genomics (2010) 1.05

Antimicrobial mechanism of pore-forming protegrin peptides: 100 pores to kill E. coli. Peptides (2009) 1.04

Synergistic effects of the membrane actions of cecropin-melittin antimicrobial hybrid peptide BP100. Biophys J (2009) 1.03

Cytokeratins mediate epithelial innate defense through their antimicrobial properties. J Clin Invest (2012) 1.02

Human beta-defensin 2 and beta-defensin 3 chimeric peptides reveal the structural basis of the pathogen specificity of their parent molecules. Antimicrob Agents Chemother (2010) 1.01

Pasteurella multocida expresses two lipopolysaccharide glycoforms simultaneously, but only a single form is required for virulence: identification of two acceptor-specific heptosyl I transferases. Infect Immun (2007) 1.01

Antimicrobial peptides: versatile biological properties. Int J Pept (2013) 1.01

Antibacterial peptides from plants: what they are and how they probably work. Biochem Res Int (2011) 1.00

The potential of antimicrobial peptides as biocides. Int J Mol Sci (2011) 0.99

Antibacterial activity and mechanism of a scorpion venom peptide derivative in vitro and in vivo. PLoS One (2012) 0.99

Induction by cationic antimicrobial peptides and involvement in intrinsic polymyxin and antimicrobial peptide resistance, biofilm formation, and swarming motility of PsrA in Pseudomonas aeruginosa. J Bacteriol (2008) 0.98

Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides. Front Microbiol (2013) 0.98

Intestinal microbiome of poultry and its interaction with host and diet. Gut Microbes (2013) 0.98

AVPpred: collection and prediction of highly effective antiviral peptides. Nucleic Acids Res (2012) 0.98

Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics. Pharmaceuticals (Basel) (2013) 0.98

Role of the conformational rigidity in the design of biomimetic antimicrobial compounds. Angew Chem Int Ed Engl (2010) 0.98

Strategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptides. Front Microbiol (2013) 0.98

Identification of novel glycosyltransferases required for assembly of the Pasteurella multocida A:1 lipopolysaccharide and their involvement in virulence. Infect Immun (2009) 0.98

Computational studies of protegrin antimicrobial peptides: a review. Peptides (2010) 0.97

Intestinal barrier in inflammatory bowel disease. World J Gastroenterol (2014) 0.97

The Importance of Heparan Sulfate in Herpesvirus Infection. Virol Sin (2008) 0.97

OmpT outer membrane proteases of enterohemorrhagic and enteropathogenic Escherichia coli contribute differently to the degradation of human LL-37. Infect Immun (2011) 0.97

Peptide-based Antifungal Therapies against Emerging Infections. Drugs Future (2010) 0.97

Membrane insertion and bilayer perturbation by antimicrobial peptide CM15. Biophys J (2007) 0.97

Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability. Am J Physiol Cell Physiol (2010) 0.96

Different effects of transcriptional regulators MarA, SoxS and Rob on susceptibility of Escherichia coli to cationic antimicrobial peptides (CAMPs): Rob-dependent CAMP induction of the marRAB operon. Microbiology (2009) 0.96

Cathelicidin administration protects mice from Bacillus anthracis spore challenge. J Immunol (2008) 0.95

Structural features governing the activity of lactoferricin-derived peptides that act in synergy with antibiotics against Pseudomonas aeruginosa in vitro and in vivo. Antimicrob Agents Chemother (2010) 0.94

Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. Peptides (2010) 0.94

Antimicrobial peptide-like genes in Nasonia vitripennis: a genomic perspective. BMC Genomics (2010) 0.94

Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatus. Antimicrob Agents Chemother (2008) 0.94

Structure-activity analysis of the dermcidin-derived peptide DCD-1L, an anionic antimicrobial peptide present in human sweat. J Biol Chem (2012) 0.94

Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice. BMC Microbiol (2009) 0.94

Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates. Antimicrob Agents Chemother (2009) 0.93

Discovery of defense- and neuropeptides in social ants by genome-mining. PLoS One (2012) 0.93

Haemophilus ducreyi SapA contributes to cathelicidin resistance and virulence in humans. Infect Immun (2010) 0.93

Safety, formulation, and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1. Probiotics Antimicrob Proteins (2013) 0.92

Comparative analysis of selected methods for the assessment of antimicrobial and membrane-permeabilizing activity: a case study for lactoferricin derived peptides. BMC Microbiol (2008) 0.92

Two hits are better than one: membrane-active and DNA binding-related double-action mechanism of NK-18, a novel antimicrobial peptide derived from mammalian NK-lysin. Antimicrob Agents Chemother (2012) 0.91

The molecular basis for antimicrobial activity of pore-forming cyclic peptides. Biophys J (2011) 0.91

Effects of hydrophobicity on the antifungal activity of alpha-helical antimicrobial peptides. Chem Biol Drug Des (2008) 0.91

Novel formulations for antimicrobial peptides. Int J Mol Sci (2014) 0.91

Deletion of mtrC in Haemophilus ducreyi increases sensitivity to human antimicrobial peptides and activates the CpxRA regulon. Infect Immun (2011) 0.90

Isolation and partial characterization of cyclic lipopeptide antibiotics produced by Paenibacillus ehimensis B7. BMC Microbiol (2013) 0.90

Role of helicity of α-helical antimicrobial peptides to improve specificity. Protein Cell (2014) 0.90

The two-component response regulator LiaR regulates cell wall stress responses, pili expression and virulence in group B Streptococcus. Microbiology (2013) 0.89

Thermodynamics of antimicrobial lipopeptide binding to membranes: origins of affinity and selectivity. Biophys J (2014) 0.89

Cationic antimicrobial peptides disrupt the Streptococcus pyogenes ExPortal. Mol Microbiol (2012) 0.89

Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7. PLoS One (2012) 0.89

Surface-immobilised antimicrobial peptoids. Biofouling (2008) 0.89

Protecting the boundary: the sentinel role of host defense peptides in the skin. Cell Mol Life Sci (2011) 0.89

Characterization of a potent antimicrobial lipopeptide via coarse-grained molecular dynamics. Biochim Biophys Acta (2011) 0.89

Bio-inspired stable antimicrobial peptide coatings for dental applications. Acta Biomater (2013) 0.89

Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis (2011) 0.89

Antimicrobial peptides and induced membrane curvature: geometry, coordination chemistry, and molecular engineering. Curr Opin Solid State Mater Sci (2013) 0.89

Characterization of a regulatory network of peptide antibiotic detoxification modules in Lactobacillus casei BL23. Appl Environ Microbiol (2013) 0.88

Antimicrobial Peptides in Human Sepsis. Front Immunol (2015) 0.88

Membrane structure and conformational changes of the antibiotic heterodimeric peptide distinctin by solid-state NMR spectroscopy. Proc Natl Acad Sci U S A (2009) 0.88

LPS inmobilization on porous and non-porous supports as an approach for the isolation of anti-LPS host-defense peptides. Front Microbiol (2013) 0.88

Temporin-SHf, a new type of phe-rich and hydrophobic ultrashort antimicrobial peptide. J Biol Chem (2010) 0.88

Honey glycoproteins containing antimicrobial peptides, Jelleins of the Major Royal Jelly Protein 1, are responsible for the cell wall lytic and bactericidal activities of honey. PLoS One (2015) 0.87

Anti-Pseudomonas activity of frog skin antimicrobial peptides in a Caenorhabditis elegans infection model: a plausible mode of action in vitro and in vivo. Antimicrob Agents Chemother (2010) 0.87

The oligo-acyl lysyl antimicrobial peptide C₁₂K-2β₁₂ exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori. Antimicrob Agents Chemother (2011) 0.87

Interactions of cationic-hydrophobic peptides with lipid bilayers: a Monte Carlo simulation method. Biophys J (2007) 0.87

MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph (1996) 39.73

The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell (1996) 17.42

Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol (2005) 13.69

Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol (2003) 11.11

Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A (1987) 8.53

Membrane fusion and exocytosis. Annu Rev Biochem (1999) 7.35

Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol (1989) 7.11

Peptide antibiotics and their role in innate immunity. Annu Rev Immunol (1995) 6.81

Peptide antibiotics. Lancet (1997) 6.76

Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol (2000) 6.62

Proteoglycans: structures and interactions. Annu Rev Biochem (1991) 6.53

Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science (1999) 6.49

Bacteriocins of lactic acid bacteria. Biochimie (1988) 6.25

Bacteriocins: developing innate immunity for food. Nat Rev Microbiol (2005) 5.77

Peptide antibiotics. Antimicrob Agents Chemother (1999) 5.76

Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest (1989) 5.21

Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature (2003) 5.14

Cationic peptides: a new source of antibiotics. Trends Biotechnol (1998) 5.10

Mammalian defensins in the antimicrobial immune response. Nat Immunol (2005) 4.84

Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J Cell Biol (1992) 4.48

Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol (1992) 4.37

Coiled coils in both intracellular vesicle and viral membrane fusion. Cell (1998) 4.26

The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol (2000) 4.10

A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science (1999) 3.90

Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry (1999) 3.88

The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem (1997) 3.82

Barrel-stave model or toroidal model? A case study on melittin pores. Biophys J (2001) 3.80

APD: the Antimicrobial Peptide Database. Nucleic Acids Res (2004) 3.60

Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol (2003) 3.56

Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis (2001) 3.54

Mammalian defensins in immunity: more than just microbicidal. Trends Immunol (2002) 3.52

Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest (1998) 3.51

Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol (2001) 3.39

Antiviral drugs in current clinical use. J Clin Virol (2004) 3.23

Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain. Appl Environ Microbiol (1997) 3.21

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest (2003) 3.19

Insect immunity: isolation and structure of cecropin D and four minor antibacterial components from Cecropia pupae. Eur J Biochem (1982) 3.17

An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry (1996) 3.16

Microbicidal cationic proteins in rabbit alveolar macrophages: a potential host defense mechanism. Infect Immun (1980) 3.13

Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother (1997) 3.12

The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem (1996) 3.08

Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob Agents Chemother (2000) 3.06

Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays (1998) 3.04

Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet (2002) 3.01

Direct inactivation of viruses by human granulocyte defensins. J Virol (1986) 3.00

Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J Biol Chem (2003) 2.94

Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry (1997) 2.87

Anti-microbial peptides: from invertebrates to vertebrates. Immunol Rev (2004) 2.80

Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem (1996) 2.78

[Sequence analysis of melittin from tryptic and peptic degradation products]. Hoppe Seylers Z Physiol Chem (1967) 2.72

Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol (2004) 2.72

Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim Biophys Acta (1998) 2.71

Cationic host defense (antimicrobial) peptides. Curr Opin Immunol (2005) 2.71

Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun (1998) 2.67

Neutron scattering in the plane of membranes: structure of alamethicin pores. Biophys J (1996) 2.63

Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J (1996) 2.59

Mode of action of the antimicrobial peptide indolicidin. J Biol Chem (1996) 2.57

The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol (2002) 2.57

The relationship between peptide structure and antibacterial activity. Peptides (2003) 2.51

Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest (1989) 2.50

Analysis of two novel classes of plant antifungal proteins from radish (Raphanus sativus L.) seeds. J Biol Chem (1992) 2.50

Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry (1992) 2.50

Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. Biochemistry (2003) 2.48

Electrically gated ionic channels in lipid bilayers. Q Rev Biophys (1977) 2.44

Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol Lett (2002) 2.44

Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim Biophys Acta (1999) 2.41

Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun (1993) 2.37

Plant defense peptides. Biopolymers (1998) 2.36

Possible existence of common internalization mechanisms among arginine-rich peptides. J Biol Chem (2001) 2.31

Defensins and other endogenous peptide antibiotics of vertebrates. J Leukoc Biol (1995) 2.25

Molecular mechanisms of bacteriocin evolution. Annu Rev Genet (1998) 2.24

Antimicrobial activity of synthetic magainin peptides and several analogues. Proc Natl Acad Sci U S A (1988) 2.24

Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature (2005) 2.23

Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol (2002) 2.21

Interaction of cationic antimicrobial peptides with model membranes. J Biol Chem (2001) 2.16

Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1. Proc Natl Acad Sci U S A (2002) 2.14

Antiendotoxin activity of cationic peptide antimicrobial agents. Infect Immun (1996) 2.13

In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob Agents Chemother (1999) 2.10

A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J Exp Med (1997) 2.09

High-throughput generation of small antibacterial peptides with improved activity. Nat Biotechnol (2005) 2.01

Impact of LL-37 on anti-infective immunity. J Leukoc Biol (2004) 2.01

MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain. Biophys J (2003) 1.99

Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120. J Biol Chem (2005) 1.99

De novo design of biomimetic antimicrobial polymers. Proc Natl Acad Sci U S A (2002) 1.95

Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit Rev Immunol (2000) 1.93

Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr Drug Targets Infect Disord (2002) 1.89

Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity. Infect Immun (1985) 1.89

The cellular target of histatin 5 on Candida albicans is the energized mitochondrion. J Biol Chem (1999) 1.87

The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol (2004) 1.78

A re-evaluation of the role of host defence peptides in mammalian immunity. Curr Protein Pept Sci (2005) 1.78

In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action. Antimicrob Agents Chemother (1999) 1.77

Antimicrobial peptides in Drosophila: structures, activities and gene regulation. Chem Immunol Allergy (2005) 1.76

Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1. J Biol Chem (2002) 1.74

Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature (1998) 1.71

The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. Biochemistry (2001) 1.70

Antimicrobial peptides from amphibian skin: what do they tell us? Biopolymers (1998) 1.70

Mechanism of antimicrobial action of indolicidin. FEMS Microbiol Lett (1998) 1.70

Retrocyclin, an antiretroviral theta-defensin, is a lectin. J Immunol (2003) 1.69

The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J Biol Chem (2004) 1.69

Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob Agents Chemother (2002) 1.69

Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc (2008) 7.92

Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res (2010) 5.23

PSICQUIC and PSISCORE: accessing and scoring molecular interactions. Nat Methods (2011) 5.01

Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell (2002) 4.94

InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Mol Syst Biol (2008) 4.61

Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov (2011) 4.16

Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol (2011) 3.49

Cerebral: a Cytoscape plugin for layout of and interaction with biological networks using subcellular localization annotation. Bioinformatics (2007) 3.39

Protein interaction data curation: the International Molecular Exchange (IMEx) consortium. Nat Methods (2012) 3.17

Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol Microbiol (2003) 3.06

Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Res (2008) 3.03

Recognition of host immune activation by Pseudomonas aeruginosa. Science (2005) 2.84

Pseudomonas Genome Database: facilitating user-friendly, comprehensive comparisons of microbial genomes. Nucleic Acids Res (2008) 2.71

Cationic host defense (antimicrobial) peptides. Curr Opin Immunol (2005) 2.71

InnateDB: systems biology of innate immunity and beyond--recent updates and continuing curation. Nucleic Acids Res (2012) 2.66

Pseudomonas aeruginosa Genome Database and PseudoCAP: facilitating community-based, continually updated, genome annotation. Nucleic Acids Res (2005) 2.61

The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol (2002) 2.57

Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin. Chem Biol (2004) 2.51

The relationship between peptide structure and antibacterial activity. Peptides (2003) 2.51

Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J Exp Med (2002) 2.40

Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biochim Biophys Acta (2006) 2.35

Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol (2006) 2.32

Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis (2013) 2.32

Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J Biol Chem (2005) 2.28

Construction of a mini-Tn5-luxCDABE mutant library in Pseudomonas aeruginosa PAO1: a tool for identifying differentially regulated genes. Genome Res (2005) 2.22

Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis. MBio (2012) 2.15

Peptide arrays on cellulose support: SPOT synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion. Nat Protoc (2007) 2.08

Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev Anti Infect Ther (2007) 2.06

ArrayPipe: a flexible processing pipeline for microarray data. Nucleic Acids Res (2004) 2.03

High-throughput generation of small antibacterial peptides with improved activity. Nat Biotechnol (2005) 2.01

Impact of LL-37 on anti-infective immunity. J Leukoc Biol (2004) 2.01

Multifunctional cationic host defence peptides and their clinical applications. Cell Mol Life Sci (2011) 1.99

Swarming of Pseudomonas aeruginosa is a complex adaptation leading to increased production of virulence factors and antibiotic resistance. J Bacteriol (2008) 1.98

An anti-infective peptide that selectively modulates the innate immune response. Nat Biotechnol (2007) 1.97

The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol (2009) 1.92

Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa. FEMS Microbiol Rev (2009) 1.91

Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun (2008) 1.91

Can innate immunity be enhanced to treat microbial infections? Nat Rev Microbiol (2004) 1.90

Sequence requirements and an optimization strategy for short antimicrobial peptides. Chem Biol (2006) 1.84

Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2005) 1.82

The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol (2004) 1.78

The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrob Agents Chemother (2011) 1.78

A re-evaluation of the role of host defence peptides in mammalian immunity. Curr Protein Pept Sci (2005) 1.78

Genome-wide identification of Pseudomonas aeruginosa exported proteins using a consensus computational strategy combined with a laboratory-based PhoA fusion screen. Genome Res (2005) 1.77

Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob Agents Chemother (2010) 1.74

Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev (2012) 1.74

Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistance. Drug Discov Today (2005) 1.74

Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. Nat Chem Biol (2013) 1.73

Evidence that plant-like genes in Chlamydia species reflect an ancestral relationship between Chlamydiaceae, cyanobacteria, and the chloroplast. Genome Res (2002) 1.72

Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob Agents Chemother (2002) 1.69

Immunomodulatory activities of small host defense peptides. Antimicrob Agents Chemother (2005) 1.67

Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility. Antimicrob Agents Chemother (2008) 1.67

Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells. J Immunol (2011) 1.65

Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr Opin Microbiol (2013) 1.63

Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide. Antimicrob Agents Chemother (2012) 1.63

Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages. PLoS One (2009) 1.61

AMPer: a database and an automated discovery tool for antimicrobial peptides. Bioinformatics (2007) 1.59

Aminoglycoside efflux in Pseudomonas aeruginosa: involvement of novel outer membrane proteins. Antimicrob Agents Chemother (2003) 1.59

Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol (2009) 1.58

Identification of genes involved in swarming motility using a Pseudomonas aeruginosa PAO1 mini-Tn5-lux mutant library. J Bacteriol (2006) 1.54

Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Biopolymers (2008) 1.51

Characterization of a proteolytically stable multifunctional host defense peptidomimetic. Chem Biol (2013) 1.49

Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations. Vaccine (2011) 1.48

INMEX--a web-based tool for integrative meta-analysis of expression data. Nucleic Acids Res (2013) 1.48

Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob Agents Chemother (2005) 1.44

The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J Immunol (2004) 1.41

Intracellular receptor for human host defense peptide LL-37 in monocytes. J Immunol (2009) 1.38

Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B. Eur J Immunol (2007) 1.37

Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways. J Immunol (2007) 1.37

The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect Immun (2008) 1.36

Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics. Antimicrob Agents Chemother (2010) 1.35

Enabling a systems biology approach to immunology: focus on innate immunity. Trends Immunol (2009) 1.35

Cationic peptides: distribution and mechanisms of resistance. Curr Pharm Des (2002) 1.35

Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides. J Biol Chem (2007) 1.33

Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem Biol (2009) 1.33

Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. J Immunol (2010) 1.32

Curating the innate immunity interactome. BMC Syst Biol (2010) 1.30

Permeabilization of fungal hyphae by the plant defensin NaD1 occurs through a cell wall-dependent process. J Biol Chem (2010) 1.28

Systems-level comparison of host responses induced by pandemic and seasonal influenza A H1N1 viruses in primary human type I-like alveolar epithelial cells in vitro. Respir Res (2010) 1.26

Fluorescent probes alter miscibility phase boundaries in ternary vesicles. J Phys Chem B (2007) 1.26

The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J Leukoc Biol (2006) 1.25

Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect Immun (2005) 1.24

Structural studies of a peptide with immune modulating and direct antimicrobial activity. Chem Biol (2010) 1.24

Antimicrobial properties of lactoferrin. Biochimie (2008) 1.24

Creeping baselines and adaptive resistance to antibiotics. Drug Resist Updat (2011) 1.24

Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2008) 1.24

ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease. Clin Immunol (2008) 1.23

Identification of novel antibacterial peptides by chemoinformatics and machine learning. J Med Chem (2009) 1.23

The global access initiative at the University of British Columbia (UBC): Availability of UBC discoveries and technologies to the developing world. J Pharm Sci (2009) 1.23

The sensor kinase PhoQ mediates virulence in Pseudomonas aeruginosa. Microbiology (2009) 1.23

Role of the novel OprD family of porins in nutrient uptake in Pseudomonas aeruginosa. J Bacteriol (2006) 1.22

Swarming of Pseudomonas aeruginosa is controlled by a broad spectrum of transcriptional regulators, including MetR. J Bacteriol (2009) 1.21

The Lon protease of Pseudomonas aeruginosa is induced by aminoglycosides and is involved in biofilm formation and motility. Microbiology (2007) 1.21

Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides. Chem Biol Drug Des (2006) 1.20

The role of sphingosine-1-phosphate transporter Spns2 in immune system function. J Immunol (2012) 1.20

Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother (2009) 1.19

ProbeLynx: a tool for updating the association of microarray probes to genes. Nucleic Acids Res (2004) 1.17

Effect of divalent cations on the structure of the antibiotic daptomycin. Eur Biophys J (2007) 1.17

Cathelicidins and functional analogues as antisepsis molecules. Expert Opin Ther Targets (2007) 1.16